Achieve Life Sciences ACHV Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $52.45M+14.1% | $54.88M+40.5% | $52.34M+67.4% | $50.11M+97.5% | $45.98M+86.5% | ||
| $908K-41.5% | $819K-62.4% | $765K-72.4% | $939K-70.5% | $1.55M-49.8% | ||
| $460K+357% | $232K+131% | -$7K+99.6% | -$304K+86.0% | -$179K+93.3% | ||
| —— | —— | —— | —— | —— | ||
| -$51.99M-12.6% | -$54.65M-37.2% | -$52.35M-58.9% | -$50.42M-83.1% | -$46.16M-69.0% | ||
| -$1.10+17.9% | -$1.28-4.1% | -$1.38-24.3% | -$1.46-33.9% | -$1.34-5.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is Achieve Life Sciences profitable?
- Achieve Life Sciences is not currently profitable: it reported a net loss of $52.0M over the trailing twelve months.
- What is Achieve Life Sciences's earnings per share?
- Achieve Life Sciences's diluted EPS over the trailing twelve months is $-1.10.
- Where does Achieve Life Sciences's income statement data come from?
- Every line is extracted from Achieve Life Sciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.